Vnitr Lek 2012, 58(2):154-161

Good's syndrome (thymoma associated hypogammalobulinaemia) - 2 case reports

P. Králíčková^1,*, R. Slezák², M. Vošmik³, P. Malá³, H. Hornychová⁴, J. Brožík⁵, B. Melichar⁶

¹ Ústav klinické imunologie a alergologie Lékařské fakulty UK a FN Hradec Králové, přednosta prof. RNDr. Jan Krejsek, CSc.

² Stomatologická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta doc. MUDr. Radovan Slezák, CSc.

³ Klinika onkologie a radioterapie Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jiří Petera, Ph.D.

⁴ Fingerlandův ústav patologie Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Aleš Ryška, Ph.D.

⁵ Radiologická klinika, Fakultní nemocnice a Lékařská fakulta UK v Hradci Králové, prof. MUDr. Pavel Eliáš, CSc.

⁶ Onkologická klinika, Fakultní nemocnice a Lékařská fakulta Olomouc, prof. MUDr. Bohuslav Melichar, Ph.D.

Although tumours of the thymus are rare, they are common among neoplasms of the anterior superior mediastinum. They usually exhibit indolent behavior, but do have the capacity to invade surrouding structures. Their metastatic potential is low. Paraneoplastic complications including autoimmune disorders (frequently myastenia, cytopenia) or combined immunodeficiency are of clinical significance. Here we report two case reports of thymoma patients associated with secondary immunodeficiency known as Good's syndrom. The first case exhibited as symptomatic combinated immunodeficiency with oral lichen planus. Thymoma findings was accidental. Severity of immunodeficiency required long-term intravenous immunoglobulins supplementations, even after complete surgical resection. On the other hand, the second case manifested by signs of advanced local tumour growth. Antibiotic prophylaxis was selected as immunodeficiency treatment.

Keywords: thymoma; combined immunodeficiency; Good's syndrom; lichen planus

Received: June 30, 2011; Accepted: September 23, 2011; Published: February 1, 2012  Show citation